SOPHiA GENETICS (SOPH) Total Debt (2020 - 2025)

SOPHiA GENETICS (SOPH) reported Total Debt of $47.7 million for Q4 2025, up 260.6% on a YoY basis from $13.2 million in Q4 2024, and little changed sequentially from $47.6 million in Q3 2025.

SOPHiA GENETICS (SOPH) Total Debt (2020 - 2025) Analysis & Trends

SOPHiA GENETICS (SOPH) has 3 years of Total Debt data on file, last reported at $47.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Total Debt rose 260.6% year-over-year to $47.7 million; the trailing twelve-month figure through Dec 2025 stood at $47.7 million (up 260.6% YoY), and the FY2025 full-year result was $47.7 million, up 260.6% from the prior year.
  • Total Debt held at $47.7 million in Q4 2025, from $47.6 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $47.7 million in Q4 2025 to a low of $13.2 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Veeva Systems 31.61 Bn 24.30 Bn 662.02 Mn -
2 BrightSpring Health Services 14.73 Bn 13.83 Bn 482.22 Mn 2.50 Bn
3 Healthequity 8.26 Bn 8.00 Bn 256.31 Mn 942.66 Mn
4 Hinge Health 5.90 Bn 5.58 Bn 154.23 Mn -
5 10x Genomics 5.90 Bn 5.36 Bn 106.18 Mn -
6 MiniMed 4.52 Bn 4.22 Bn 480.00 Mn -
7 Waystar Holding 4.42 Bn 4.36 Bn 216.84 Mn 1.47 Bn
8 Doximity 3.93 Bn 3.18 Bn 125.97 Mn -
9 Privia Health 3.17 Bn 2.75 Bn - -
10 SOPHiA GENETICS 382.28 Mn 311.99 Mn 14.69 Mn 47.73 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 47.73 Mn
Sep 30, 2025 47.58 Mn
Jun 30, 2025 47.47 Mn
Mar 31, 2025 13.32 Mn
Dec 31, 2024 13.24 Mn
Sep 30, 2024 13.16 Mn
Jun 30, 2024 13.34 Mn
Dec 31, 2020 3.33 Mn